z-logo
Premium
LC‐ESI‐MS/MS analysis and pharmacokinetics of heterophyllin B, a cyclic octapeptide from Pseudostellaria heterophylla in rat plasma
Author(s) -
Zhao WaiOu,
Pang Li,
Dong Ning,
Yang Shu
Publication year - 2015
Publication title -
biomedical chromatography
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.4
H-Index - 65
eISSN - 1099-0801
pISSN - 0269-3879
DOI - 10.1002/bmc.3481
Subject(s) - chromatography , chemistry , formic acid , ammonium formate , analyte , pharmacokinetics , extraction (chemistry) , selected reaction monitoring , chromatographic separation , high performance liquid chromatography , mass spectrometry , tandem mass spectrometry , pharmacology , medicine
Heterophyllin B (HB) is a cyclic octapeptide isolated from Pseudostellaria heterophylla . HB is used as the quality control index for evaluating P. heterophylla in the Chinese Pharmacopoeia . A rapid and sensitive LC‐ESI‐MS/MS method was developed and validated for the analysis of HB in rat plasma. Sample preparation consisted of a solid‐phase extraction step for the removal of interference and preconcentration of the target analyte HB and the internal standard N ‐acetylcysteine before chromatographic analysis by MS/MS detection. The separation of HB and N ‐acetylcysteine was performed using a Hypersil GOLD TM C 18 column and a mixture of methanol–water (60:40, v/v) containing 10 mmol/L ammonium formate and 0.1% formic acid as the mobile phase. The determination step was optimized in the selected reaction monitoring mode for the highly selective and sensitive quantitation of HB in rat plasma. Intra‐ and inter‐assay precision (as relative standard deviation) was ≤9.1%, and accuracy was between 92.6 and 102.7%. The validated method was successfully applied to quantify HB concentrations up to 7 h after tail intravenous injections of 2.08, 4.16 and 8.32 mg/kg HB in rats. The LC‐MS/MS method identified the relevant pharmacokinetic parameters of HB and its studied analog. Copyright © 2015 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here